Synchron

Synchron

Develops brain-computer interface technology for patients

About Synchron

Simplify's Rating
Why Synchron is rated
B+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated A on Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$134.3M

Headquarters

New York City, New York

Founded

2016

Overview

Synchron develops brain-computer interface (BCI) technology that enables individuals, especially those with severe paralysis, to control digital devices using their thoughts. Their main product involves a minimally invasive endovascular procedure for implanting the BCI, which is similar to placing stents and avoids the need for open brain surgery. This approach makes the technology safer and more accessible for patients with neurological conditions that limit their ability to communicate or move. Unlike competitors, Synchron focuses on providing a solution that enhances patient autonomy and social connection through advanced BCI technology. The company's goal is to empower patients by improving their quality of life and transforming the way they interact with the world.

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Apple could accelerate BCI technology development and market reach.
  • Chiral(TM) positions Synchron as a leader in AI-integrated BCI technology.
  • NVIDIA's AI integration improves brain signal processing accuracy and efficiency.

What critics are saying

  • Competition from Neuralink could impact Synchron's market position and media attention.
  • Ethical concerns about brain implants may hinder technology adoption and acceptance.
  • Dependence on tech partnerships poses risks if collaborations don't meet expectations.

What makes Synchron unique

  • Synchron's BCI technology uses a minimally invasive endovascular procedure, unlike open brain surgery.
  • The company integrates AI with BCI, enhancing product functionality and appeal.
  • Synchron's stent-like implant has FDA clearance for human trials, indicating regulatory progress.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$134.3M

Above

Industry Average

Funded Over

5 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$75M
Synchron
$100M
Oura

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 1%

2 year growth

↑ 13%
Blooloop
May 19th, 2025
Apple devices to be controlled via brain implants and users' thoughts

Apple is working with neurotechnology company Synchron to develop devices including iPhones that could be controlled using brain implants and users' thoughts.

Forbes
May 15th, 2025
Apple Is Developing Tech So Users Can Control Devices With Only Their Thoughts

Apple CEO, Tim Cook, unveils the latest generation of iPhones.Getty Images. Apple is boldly embracing brain-computer interface (BCI) technology to enable users to control its devices using only their thoughts—a novel frontier for the company.Earlier this week, it was announced that the tech giant is working with Synchron, a company that has been pioneering BCI research and work for more than a decade. The company was founded by Dr. Tom Oxley, a neurointerventionalist and technologist. Synchron has developed a stent-like implant that can be inserted using a (relatively) minimally invasive procedure on an individual’s motor cortex. The stent was reportedly granted FDA clearance for human trials in 2021, and works to detect brain signals and translate them into software-enabled relays; in the case of an Apple device, the relays can select icons on a iPhone or iPad

MacTech
May 13th, 2025
Apple working with Synchron on a brain-computer interface

Apple working with Synchron on a brain-computer interface.

PC Tablet
May 13th, 2025
Is Apple About to Let You Control Your iPhone With Just Your Thoughts?

The company is collaborating with Synchron, a neurotechnology firm, to develop a brain-computer interface (BCI) that allows individuals to operate Apple devices without physical movement.

eWeek
Mar 26th, 2025
AI-Powered Neural Interface Connects Minds to Machines - No Brain Surgery Needed

Synchron, a brain-computer interface company that recently showcased its technology at NVIDIA's GTC conference, claims its interface can help people with paralysis and other severe physical disabilities to control hands-free technology and better interact with the world.

Recently Posted Jobs

Sign up to get curated job recommendations

Synchron is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

đź’ˇ
We update Synchron's jobs every few hours, so check again soon! Browse all jobs →